基本信息 产品详情 公司简介 推荐产品
网站主页 VEGFB, HUMAN, 重组蛋白 (HFC) VEGFB, Human, 重组蛋白 (hFc)
  • VEGFB, Human, 重组蛋白 (hFc)|TMPY-04327|TargetMol

VEGFB, Human, 重组蛋白 (hFc)|TMPY-04327|TargetMol

VEGFB Protein, Human, Recombinant (hFc)
1350 20μg 起订
上海 更新日期:2026-05-09

TargetMol 中国(陶术生物)

VIP1年
联系人:邵经理
电话:400-821-0310拨打
手机:15002144251 拨打
邮箱:xuexiang.shao@tsbiochem.com

产品详情:

中文名称:
VEGFB, Human, 重组蛋白 (hFc)
英文名称:
VEGFB Protein, Human, Recombinant (hFc)
品牌:
TargetMol
产地:
美国
保存条件:
Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months
产品类别:
抑制剂
种属:
Human
表达系统:
HEK293 Cells
蛋白长度:
A DNA sequence encoding the human VEGFB (NP_003368.1) (Pro22-Ala207) was expressed with the Fc region of human IgG1 at the N-terminus. Predicted N terminal: Glu
标签:
N-hFc
货号:
T011|TMPY-04327

Product Introduction

Bioactivity

名称VEGFB Protein, Human, Recombinant (hFc)
描述Vascular endothelial growth factor-B (VEGF-B) is closely related to VEGF-A, an effector of blood vessel growth during development and disease and a strong candidate for angiogenic therapies. In detail, VEGFB can positively prevent the Ang II-induced rising in the size of cardiomyocyte as well as reduce Ang II-induced mRNA and protein levels of β-MHC (β-myosin heavy chain), BNP (brain natriuretic peptide), and ANP (atrial natriuretic peptide). Moreover, VEGFB can regulate the decline of the Ang II-induced rising in Ca2+.
存储条件Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months
血管内皮生长因子;VRF;VEGFL;vascular endothelial growth factor B;TargetMol

公司简介


成立日期 (14年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生物化工,化学试剂,生物技术服务

VEGFB, Human, 重组蛋白 (hFc)相关厂家报价

内容声明
拨打电话 立即询价